Taro Pharmaceutical Industries Ltd expected to post earnings of 88  cents a share - Earnings Preview

Taro Pharmaceutical Industries

24/05/2022 21:02

* Taro Pharmaceutical Industries Ltd  TARO.N   TARO.K  is
expected
to show a fall in quarterly revenue when it reports  results on
May 26. 
    * The Haifa Israel-based   company is expected to report  a
0.9% decrease in revenue to $147.011 million from $148.34
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Taro Pharmaceutical
Industries Ltd is for earnings of 88 cents per share. For the
same quarter last year, the company reported a loss of 78 cents
per share.
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $73​, above​ its last closing
price of $36.55. ​​​

This summary was machine generated May 24 at 20:02 GMT.  All
figures in US dollars  unless otherwise stated